Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
JAAPA ; 35(8): 50-54, 2022 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-35881718

RESUMO

ABSTRACT: The COVID-19 pandemic resulted in many challenges for the healthcare system. This article describes how an ambulatory orthopedic practice transitioned to telemedicine in order to continue to provide effective, efficient, and safe care for patients. Although this discipline relies heavily on physical assessment and examination, telemedicine can be successfully implemented in this area.


Assuntos
COVID-19 , Ortopedia , Telemedicina , Assistência Ambulatorial , COVID-19/epidemiologia , Humanos , Pandemias , SARS-CoV-2 , Telemedicina/métodos
2.
Gynecol Oncol Rep ; 41: 100995, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35574241

RESUMO

Abdominal wall endometriosis with subsequent transformation to clear cell carcinoma is quite rare. The pathogenesis and pattern of this transformation is not well known; hence evaluation and management guidelines are not well established. We highlight a case of clear cell adenocarcinoma arising from the anterior abdominal wall in a previous cesarean section scar treated with excision and the unique addition of Trastuzumab for adjuvant chemotherapy.

3.
JAAPA ; 34(12): 27-30, 2021 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-34813532

RESUMO

ABSTRACT: Overactive bladder can affect patients at any age; however, it is more common in women over age 40 years. Many treatments are available, including behavioral interventions, antimuscarinics, beta-3 agonists, and botulinum toxin injection. This article describes a patient who was successfully treated with percutaneous tibial nerve stimulation after traditional treatment failed.


Assuntos
Estimulação Elétrica Nervosa Transcutânea , Bexiga Urinária Hiperativa , Adulto , Terapia Comportamental , Feminino , Humanos , Antagonistas Muscarínicos , Nervo Tibial , Resultado do Tratamento , Bexiga Urinária Hiperativa/terapia
4.
Cureus ; 13(7): e16476, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-34430092

RESUMO

Marjolin's ulcer is a rare, often aggressive squamous cell malignancy identified in previously injured areas or those affected by chronic inflammation. It often develops in deep wounds that are slow to heal or allowed to heal by secondary intention. Few reports and small case series about Marjolin's ulcer have been published. We present a unique case with well-differentiated keratinized squamous cell carcinoma arising from a mesh-related vaginocutaneous fistula with superimposed osteomyelitis. The risk of cancerous transformation leading to Marjolin's ulcer in non-healing traumatic wounds is 8.1% and 2.6% in a fistula associated with purulent-inflammatory bone diseases. Approximately 1.7% of chronic cutaneous ulcers undergo neoplastic transformation, with a disposition to squamous cell carcinoma. Women experiencing mesh complications may require multiple procedures to address these issues and, therefore, should have them addressed in a timely manner to allow for the best patient outcome. Treatment optimization on a whole should incorporate the goals outlined by the American Urogynecologic Society and the International Urogynecological Association. These include the use of relevant evidence to help guide the management of mesh complications as well as identifying the gaps in currently available evidence, developing a treatment algorithm to be used for shared decision making, and identifying provider and healthcare facility characteristics that may optimize treatment outcomes specific to mesh complications.

5.
JAAPA ; 34(7): 29-31, 2021 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-34162806

RESUMO

ABSTRACT: Febrile neutropenia is an oncologic emergency with serious consequences. Granulocyte colony stimulating factors (G-CSFs), used to stimulate neutrophil production to prevent febrile neutropenia, can cause bone pain in more than 25% of patients. Severe bone pain may not respond to acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, or dose reduction of the G-CSF agent. A study found that patients taking loratadine had fewer treatment-associated adverse reactions and discontinuations than those on naproxen. Although more research is needed, loratadine's tolerability, ease of administration, and potential benefit mean that it should be considered for management of pegfilgrastim-associated bone pain. This article describes a patient whose G-CSF-induced bone pain was completely alleviated by loratadine.


Assuntos
Doenças Ósseas , Fator Estimulador de Colônias de Granulócitos/efeitos adversos , Loratadina/uso terapêutico , Dor Musculoesquelética , Doenças Ósseas/tratamento farmacológico , Humanos , Dor Musculoesquelética/tratamento farmacológico , Proteínas Recombinantes
6.
J Nurse Pract ; 17(2): 218-221, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33106751

RESUMO

Telehealth includes health care services provided using audio and video technology. Telehealth was originally developed to provide basic care to rural and underserved patients. Higher rates of use of telehealth are now standard in many practices since the coronavirus disease 2019 pandemic. Increasing emphases on patient satisfaction, providing efficient and quality care, and minimizing costs have also led to higher telehealth implementation. Patients and providers have enjoyed the benefits of telehealth, but widespread adoption has been hindered by regulatory, legal, and reimbursement barriers. Recent legislative initiatives have advocated for further telehealth advancements, especially with the rapid implementation of telehealth in the times of coronavirus disease 2019.

7.
JAAPA ; 32(12): 11-12, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31770299

RESUMO

In small clinical trials, dehydroepiandrosterone (DHEA) has been found to relieve symptoms associated with postmenopausal conditions and infertility in women. DHEA may provide a cost-effective alternative to typical hormone therapies. Because of a lack of long-term and large-scale studies, only intravaginal DHEA supplementation is approved and recommended for treatment. Further investigation of DHEA supplementation is needed and encouraged to determine its safety and effectiveness.


Assuntos
Desidroepiandrosterona/uso terapêutico , Dispareunia/tratamento farmacológico , Técnicas de Reprodução Assistida , Doenças Vaginais/tratamento farmacológico , Doenças da Vulva/tratamento farmacológico , Administração Intravaginal , Administração Oral , Atrofia , Feminino , Ginecologia , Humanos , Menopausa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...